Alnylam Pharmaceuticals (ALNY) Q2 2014 Earnings

8MayConfirmed
Q3 2013
Q4 2013
Q1 2014
Q2 2014
-0.59
-0.49
-0.39
-0.29

Details

Expected EPS
-0.59
Actual EPS
-0.39
Surprise EPS
0.2
Surprise Percent
+33.9%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.39 per share for Q2 2014.

0 Comments

Share your thoughts